Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of $117.00. Patrick Wood’s rating is based on a ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to $138.00. Lee Hambright has given his Buy rating due to a ...

2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, demonstrating strong performance across its business segments.

Welcome to Abbott's Fourth Quarter 2024 Earnings Conference Call. (Operator Instructions) This call is being recorded by Abbott. With the exception of any participant's questions asked during the ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

(RTTNews) - Abbott Laboratories (ABT) revealed a profit for its fourth quarter that increased from last year in line with the Street estimates. The company's bottom line totaled $9.229 billion ...

Also Read: Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System CEO Robert Ford outlined key growth opportunities for the Diabetes Care division.

Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion ...

Abbott Elementary has had its future confirmed, with the show being renewed for a fifth season by ABC. The mockumentary ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. In his recent appearance on CNBC’s Squawk on the Street, Jim Cramer started ...

2025 Adjusted Operating Margin Forecast: 23.5% to 24% of sales. 2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, ...

David Roman; Analyst; Goldman Sachs & Company, Inc. Good morning, and thank you for standing by. Welcome to Abbott's Fourth Quarter 2024 Earnings Conference Call. (Operator Instructions) This call is ...